Issue 2/2012
Special Issue: Kynurenines and the nervous system: therapeutic perspectives
Content (19 Articles)
Modifications on the carboxylic function of kynurenic acid
Ferenc Fülöp, István Szatmári, József Toldi, László Vécsei
Preparation and properties of nanoscale containers for biomedical application in drug delivery: preliminary studies with kynurenic acid
V. Hornok, T. Bujdosó, J. Toldi, K. Nagy, I. Demeter, C. Fazakas, I. Krizbai, L. Vécsei, I. Dékány
Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro
Erin K. Stachowski, Robert Schwarcz
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Flavio Moroni, Andrea Cozzi, Maria Sili, Guido Mannaioni
The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures
J. Szyndler, P. Maciejak, D. Turzyńska, A. Sobolewska, J. Walkowiak, A. Płaźnik
A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study
Ildikó Demeter, Károly Nagy, Levente Gellért, László Vécsei, Ferenc Fülöp, József Toldi
Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice
Sara K. Olsson, Markus K. Larsson, Sophie Erhardt
Behavioural studies with a newly developed neuroprotective KYNA-amide
Levente Gellért, Dániel Varga, Marian Ruszka, József Toldi, Tamás Farkas, István Szatmári, Ferenc Fülöp, László Vécsei, Zsolt Kis
Recent rodent models for Alzheimer’s disease: clinical implications and basic research
Nady Braidy, Pablo Muñoz, Adrian G. Palacios, Gloria Castellano-Gonzalez, Nibaldo C. Inestrosa, Roger S. Chung, Perminder Sachdev, Gilles J. Guillemin
The kynurenine system and immunoregulation
Yvette Mándi, László Vécsei
Kynurenines and intestinal neurotransmission: the role of N-methyl-d-aspartate receptors
József Kaszaki, Dániel Érces, Gabriella Varga, Andrea Szabó, László Vécsei, Mihály Boros
The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications
Judit Füvesi, Cecilia Rajda, Krisztina Bencsik, József Toldi, László Vécsei
New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio
Tomasz Kocki, Sebastian Wnuk, Renata Kloc, Janusz Kocki, Björn Owe-Larsson, Ewa M. Urbanska
The role of the kynurenine metabolism in major depression
Aye-Mu Myint, Markus J. Schwarz, Norbert Müller
The possible role of the kynurenine pathway in anhedonia in adolescents
Vilma Gabbay, Benjamin A. Ely, James Babb, Leonard Liebes
Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage
Trevor W. Stone, Caroline M. Forrest, Nicholas Stoy, L. Gail Darlington
Kynurenines in Parkinson’s disease: therapeutic perspectives
Dénes Zádori, Péter Klivényi, József Toldi, Ferenc Fülöp, László Vécsei
Kynurenines and headache
Árpád Párdutz, Annamária Fejes, Zsuzsanna Bohár, Lilla Tar, József Toldi, László Vécsei